An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.
An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.
复制标题
DOI:
10.1111/j.1537-2995.2010.02748.x
复制
发表时间:
2010-12
期刊:
影响因子:
2.9
通讯作者:
Fialkow LB
中科院分区:
文献类型:
--
作者:
Blumberg N;Heal JM;Gettings KF;Phipps RP;Masel D;Refaai MA;Kirkley SA;Fialkow LB
Cardiopulmonary adverse events after transfusion include acute lung injury (TRALI) and circulatory overload (TACO), which are potentially lethal and incompletely understood. To determine whether the incidence of TRALI and TACO was affected by leukoreduction we conducted a retrospective, before and after study of acute transfusion reactions for the seven years prior to and after introduction of universal leukoreduction in 2000, involving 778,559 blood components. Substantial decreases occurred in the rates of TRALI (−83%; from 2.8 cases per 100,000 components pre- to 0.48 post-universal leukoreduction; p=0.01), TACO (−49%; 7.4 to 3.8 cases per 100,000; p=0.03) and febrile reactions (−35%; 11.4 to 7.4 cases per 10,000; p<0.0001). The incidence of allergic reactions remained unchanged (7.0 per 100,000 pre- and post-universal leukoreduction). These outcomes were primarily attributable to decreased TRALI/TACO associated with RBC and platelet transfusions (−64%) with notably smaller decreases associated with FFP or cryoprecipitate transfusions (−29%). The incidence of TRALI/TACO after 28,120 washed red cell and 69,325 platelet transfusions was zero. These data suggest novel hypotheses for further testing in animal models, in prospective clinical trials, and via the new US Hemovigilance System : (1) Is TACO or TRALI mitigated by leukoreduction? (2) Is the mechanism of TACO more complex than excessive blood volume? (3) Does washing mitigate TRALI and TACO due to platelet and RBC transfusions?
登录
查看更多内容
影响因子:
20.3
作者:
Khan, Samina Yasmin;Kelher, Marguerite R.;Silliman, Christopher C.
通讯作者:
Silliman, Christopher C.
影响因子:
8.8
作者:
Watkins, Timothy R.;Rubenfeld, Gordon D.;Nathens, Avery B.
通讯作者:
Nathens, Avery B.
影响因子:
2.9
作者:
Paglino, JC;Pomper, GJ;Snyder, EL
通讯作者:
Snyder, EL
影响因子:
1.5
作者:
Eder, Anne F.;Benjamin, Richard J.
通讯作者:
Benjamin, Richard J.
影响因子:
1.9
作者:
Popovsky, Mark A.
通讯作者:
Popovsky, Mark A.